Unlock AI-driven, actionable R&D insights for your next breakthrough.

Carboxymethyl Chitosan: Comprehensive Analysis Of Synthesis, Properties, And Advanced Applications In Biomedical And Industrial Fields

APR 14, 202655 MINS READ

Want An AI Powered Material Expert?
Here's PatSnap Eureka Materials!
Carboxymethyl chitosan (CMC) represents a water-soluble derivative of chitosan obtained through carboxymethylation of hydroxyl and/or amino groups on the chitosan backbone. This modification significantly enhances solubility, biocompatibility, and functional versatility compared to native chitosan, enabling widespread applications in ophthalmology 1, hemostatic formulations 10, tissue engineering 3, antimicrobial textiles 11, and drug delivery systems 6. The degree of substitution (DS), molecular weight, and substitution site (O-carboxymethyl vs. N-carboxymethyl vs. N,O-carboxymethyl) critically determine the material's physicochemical and biological performance 815.
Want to know more material grades? Try PatSnap Eureka Material.

Molecular Structure And Chemical Composition Of Carboxymethyl Chitosan

Carboxymethyl chitosan is synthesized by introducing carboxymethyl groups (-CH₂COOH) onto the chitosan molecule, which contains three reactive sites: the primary hydroxyl group at C6, the secondary hydroxyl group at C3, and the amino group at C2 16. The electronegativity difference between oxygen and nitrogen results in preferential nucleophilic substitution at hydroxyl sites, with the primary alcohol (C6) exhibiting higher reactivity than the secondary alcohol (C3) 16. Consequently, the predominant products are O-carboxymethyl chitosan (substitution at C6), N-carboxymethyl chitosan (substitution at amino groups), or N,O-carboxymethyl chitosan (mixed substitution) 1316.

The degree of substitution (DS) quantifies the average number of carboxymethyl groups per glucosamine unit and typically ranges from 0.2 to 1.8 818. A DS of 0.95 (95% substitution) has been reported for commercial-grade CMC 16, while highly substituted variants achieve DS values of 1.0–1.8 with viscosity-average molecular weights of 7.9×10⁵ to 9.0×10⁵ g/mol and deacetylation degrees of 85–95% 18. The substitution pattern profoundly influences solubility: CMC with >50% amino group substitution (fully carboxymethylated) is typically insoluble at pH ≤5, whereas CMC with 20–50% amino substitution (e.g., 25–35%) remains acid-soluble at pH 2–5, enabling formulation in acidic media such as lactic acid solutions 7.

Key structural parameters include:

  • Molecular weight: Ranges from 1.6×10³ to 8.0×10⁵ Da depending on the parent chitosan and reaction conditions 518
  • Degree of deacetylation (DD): Typically 80–100% for the starting chitosan 5, with final CMC products retaining 85–95% DD 18
  • Viscosity: 23.0 mPa·s (1% solution, 20°C) for standard-grade CMC 16
  • pH: Aqueous solutions exhibit pH 6.8 16, though acid-soluble variants dissolve at pH 2–5 7
  • Appearance: Off-white to light yellow powdery solid 16

The chemical reaction for O-carboxymethylation can be represented as:

Chitosan-OH + ClCH₂COONa (NaOH, isopropanol) → Chitosan-O-CH₂COONa + NaCl

For N-carboxymethylation:

Chitosan-NH₂ + ClCH₂COOH (alkaline conditions) → Chitosan-NH-CH₂COOH

Synthesis Routes And Process Optimization For Carboxymethyl Chitosan

Conventional Alkali-Mediated Carboxymethylation

The most widely adopted synthesis route involves alkalinization of chitosan followed by reaction with monochloroacetic acid or its sodium salt in alcoholic media 815. A representative protocol comprises:

  1. Alkalinization: Chitosan powder is suspended in 30–50% NaOH solution (8–10 times the chitosan weight) and treated for 24 hours to swell the polymer matrix and activate reactive sites 8
  2. Carboxymethylation: After solid-liquid separation, the alkalized chitosan is dispersed in 95% ethanol (8–10 times chitosan weight), and sodium monochloroacetate (variable molar ratio to chitosan) is added 8. The reaction proceeds at 50–60°C under reduced pressure (<0.09 MPa) for 6–8 hours 8
  3. Neutralization and purification: The pH is adjusted to 7.5–8.5, followed by ethanol washing and drying 8

This method enables precise control of DS by varying the molar ratio of monochloroacetate to chitosan, thereby tailoring CMC for specific applications (e.g., wound healing, moisturizing, hemostasis) 8.

Site-Selective O-Carboxymethylation Via Schiff Base Protection

To achieve selective C6 substitution while preserving amino groups, a three-step protection-substitution-deprotection strategy has been developed 15:

  1. Amino protection: Chitosan reacts with benzaldehyde to form imine (Schiff base) linkages at amino groups, temporarily blocking N-substitution 15
  2. Carboxymethylation: The benzaldehyde-modified chitosan undergoes carboxymethylation with chloroacetic acid in isopropanol under alkaline conditions, yielding benzaldehyde-modified O-CMC 15
  3. Deprotection: Immersion in acidic solution (pH <5) for 48 hours hydrolyzes the imine bonds, regenerating free amino groups and producing pure O-CMC 15

This O-CMC exhibits superior procoagulant activity, biodegradability, and antibacterial properties compared to N,O-CMC or N-CMC, and demonstrates enhanced adsorption of anionic species, proteins, and heavy metal ions 15.

One-Pot Synthesis From Chitin

An integrated deacetylation-carboxymethylation process directly converts chitin to high-DS, high-MW CMC 18:

  1. Chitin is dissolved in 35–45 wt% strong alkaline solution at 0–10°C 18
  2. Deacetylation proceeds at 70–100°C 18
  3. Chloroacetic acid is added in situ to perform carboxymethylation without intermediate isolation 18

This streamlined approach yields CMC with DS 1.0–1.8, MW 7.9×10⁵–9.0×10⁵ g/mol, and DD 85–95%, offering improved mechanical properties for film and hydrogel applications 18.

Quaternization And Advanced Derivatization

Quaternized carboxymethyl chitosan (QCMC) is synthesized by reacting N-substituted CMC with iodomethane in N-methyl-2-pyrrolidone (NMP) at pH 9 (adjusted with 1 M NaOH) for 12 hours, followed by anion exchange to obtain chloride or bromide salts 5. The degree of quaternization ranges from 20.3% to 41.5% 5. QCMC exhibits enhanced antimicrobial activity and mucoadhesive properties, making it suitable for ophthalmic and oral drug delivery 514.

Critical Process Parameters

  • Temperature: 50–60°C for carboxymethylation 8; 70–100°C for integrated chitin conversion 18
  • Reaction time: 6–8 hours for standard protocols 8; 12 hours for quaternization 5
  • Solvent: Isopropanol or ethanol (95%) as reaction medium 815
  • Alkalinity: 30–50% NaOH for alkalinization 8; pH 9 for quaternization 5
  • Molar ratio: Monochloroacetate-to-chitosan ratio determines DS 8

Physicochemical Properties And Structure-Function Relationships

Solubility And pH-Dependent Behavior

Native chitosan is soluble only in dilute acidic solutions (pH <6) due to protonation of amino groups, limiting its utility in neutral or alkaline environments. Carboxymethylation introduces anionic carboxyl groups, conferring water solubility across a broad pH range 716. However, solubility is DS-dependent:

  • Acid-soluble CMC (20–50% amino substitution): Soluble at pH 2–5 in concentrations up to 5 w/w% 7
  • Fully carboxymethylated CMC (>50% amino substitution): Insoluble at pH ≤5 but soluble at neutral to alkaline pH 7

This tunable solubility enables formulation flexibility; for instance, acid-soluble CMC can be combined with chitosan in lactic acid solutions to create homogeneous antimicrobial films with enhanced bioactivity and reduced rigidity 7.

Viscosity And Rheological Characteristics

CMC solutions exhibit pseudoplastic (shear-thinning) behavior, with viscosity decreasing under applied shear. A 1% aqueous solution at 20°C typically displays viscosity of 23.0 mPa·s 16. Viscosity increases with molecular weight and concentration, and decreases with temperature. For ophthalmic applications, viscoelastic CMC solutions (0.5–2.0% w/v) provide lubrication and tissue protection during intraocular surgery 14.

Mechanical Properties Of CMC-Based Materials

Films and hydrogels derived from high-MW CMC (7.9×10⁵–9.0×10⁵ g/mol, DS 1.0–1.8) exhibit tensile strengths of 30–50 MPa and elongation at break of 15–25%, with elastic moduli in the range of 0.8–1.5 GPa 18. These mechanical properties are superior to those of low-MW or low-DS CMC, making high-performance CMC suitable for load-bearing tissue engineering scaffolds and durable wound dressings 18.

Thermal Stability And Degradation

Thermogravimetric analysis (TGA) reveals that CMC undergoes initial weight loss at 80–120°C (moisture evaporation), followed by major decomposition at 220–280°C (decarboxylation and polymer backbone degradation) 3. The onset decomposition temperature increases with DS and MW, indicating enhanced thermal stability. Itaconylated CMC cross-linked gels exhibit improved thermal resistance, with decomposition onset shifted to 250–300°C 3.

Chemical Stability And Biodegradability

CMC is stable in neutral aqueous solutions for extended periods (>12 months at 4°C) but undergoes gradual hydrolytic degradation in acidic (pH <4) or strongly alkaline (pH >10) environments 15. Enzymatic degradation by lysozyme and chitosanase proceeds more slowly than for native chitosan due to steric hindrance from carboxymethyl groups, with half-lives of 4–8 weeks in vitro 15. This controlled biodegradability is advantageous for sustained drug release and tissue engineering applications 36.

Preparation Of Itaconylated Carboxymethyl Chitosan Cross-Linked Hydrogels

Itaconylated CMC hydrogels represent an advanced class of biomaterials with tunable mechanical properties and dual cross-linking networks 3. The synthesis involves:

  1. Itaconylation: CMC reacts with itaconic acid in the presence of a carbodiimide coupling agent (e.g., EDC/NHS) to graft itaconyl groups onto the polymer backbone 3
  2. Primary cross-linking: The itaconylated CMC is cross-linked via free-radical polymerization initiated by ammonium persulfate (APS) and N,N,N',N'-tetramethylethylenediamine (TEMED), achieving a pre-cross-linking degree of 5–40% 3
  3. Secondary cross-linking: The pre-cross-linked gel is subjected to gamma or electron beam irradiation (dose: 10–50 kGy) to induce additional radical-mediated cross-links, forming a continuous interpenetrating network 3

The resulting hydrogels exhibit:

  • Cross-linking degree: 15–60% (combined primary and secondary cross-linking) 3
  • Elastic modulus: 10–80 kPa, tunable by adjusting pre-cross-linking degree and irradiation dose 3
  • Swelling ratio: 500–1500% in physiological saline, depending on cross-link density 3
  • Degradation rate: 20–40% mass loss over 4 weeks in PBS containing lysozyme (1 mg/mL) 3

These hydrogels support cell proliferation and adhesion, making them suitable for tissue engineering, wound healing, and hemostatic applications 3. The compact, stable interpenetrating network facilitates nutrient and waste exchange while providing mechanical integrity 3.

Biomedical Applications Of Carboxymethyl Chitosan

Ophthalmic Formulations And Corneal Edema Treatment

Hyperosmolar CMC solutions (osmolarity: 350–450 mOsm/L) are effective in treating corneal edema by drawing excess fluid from the corneal stroma via osmotic pressure 1. These formulations also suppress bacterial growth on the ocular surface, reducing infection risk 1. Viscoelastic N,O-CMC solutions (1.0–2.0% w/v) serve as surgical adjuncts in cataract extraction and intraocular lens implantation, protecting corneal endothelium and maintaining anterior chamber depth 14.

Hemostatic Sponges And Wound Dressings

CMC-based hemostatic sponges combine CMC with methyl cellulose, hydroxyethyl cellulose, and calcium alginate to achieve rapid blood clotting 10. The sponge formulation absorbs blood, swells to fill the wound cavity, and activates the coagulation cascade via platelet aggregation and fibrin network formation 10. Typical composition:

  • Carboxymethyl chitosan: 30–50% w/w 10
  • Methyl cellulose: 20–30% w/w 10
  • Hydroxyethyl cellulose: 10–20% w/w 10
  • Calcium alginate: 5–15% w/w 10

These sponges achieve hemostasis within 2–5 minutes in animal models of liver laceration and femoral artery injury 10. O-CMC-based dressings accelerate wound healing by promoting fibroblast migration, collagen deposition, and re-epithelialization, while preventing tissue adhesion and scar formation 15.

Drug Delivery Systems: Polyelectrolyte Complexes And Nanoparticles

Hydroxypropyl chitosan/CMC polyelectrolyte complexes (PECs) encapsulate hydrophobic drugs (e.g., plant extracts) via electrostatic interaction between cationic hydroxypropyl chitosan and anionic CMC 6. These micron-sized spherical particles (mean diameter: 2–10 μm) exhibit:

  • Encapsulation efficiency: 60–85% for Eupatorium adenophorum extract (AIEAS) 6
  • Sustained release: 40–60% drug release over 72 hours in pH 7.4 PBS 6
  • Biodegradability: Complete degradation within 4–6 weeks in soil 6
  • Antimicrobial synergy: Enhanced pesticidal activity compared to free drug 6

These PECs are applied as agricultural biopesticide formulations, providing controlled release and environmental compatibility 6.

Antimicrobial Textiles And UV Protection

CMC serves as a matrix for in situ synthesis of ZnO nanoparticles, which are then applied to polyester/pineapple fiber blended fabrics 11. The ZnO/CMC bio-nanocomposite treatment imparts:

  • UV protection: 10–15% improvement in UPF (Ultraviolet Protection Factor) 11
  • Antibacterial activity: Clearing zones of 15–20 mm against Klebsiella pneumoniae and *Staphylococcus
OrgApplication ScenariosProduct/ProjectTechnical Outcomes
Omnivision GmbHTreatment of corneal edema and prevention of ocular infections in ophthalmology clinics and surgical settings.Hyperosmolar Ophthalmic SolutionHyperosmolar carboxymethyl chitosan composition (350-450 mOsm/L) effectively treats corneal edema by osmotic dehydration and suppresses bacterial growth on ocular surface.
IMEIK TECHNOLOGY DEVELOPMENT CO. LTD.Tissue engineering scaffolds, aesthetic medicine fillers, hemostatic applications in surgery, and wound healing dressings.Itaconylated CMC HydrogelDual cross-linked network (5-40% pre-crosslinking plus irradiation) with elastic modulus 10-80 kPa, supports cell proliferation and provides controlled degradation (20-40% over 4 weeks).
Gyrus ACMI Inc. (Olympus Surgical Technologies America)Surgical hemostasis for liver lacerations, vascular injuries, and intraoperative bleeding control in general and trauma surgery.Hemostatic Sponge FormulationComposite sponge containing 30-50% carboxymethyl chitosan achieves rapid hemostasis (2-5 minutes) through blood absorption, swelling, and coagulation cascade activation.
South China University of TechnologyAgricultural biopesticide formulations for controlled release of plant extracts, providing antimicrobial synergy and environmental compatibility in crop protection.Hydroxypropyl Chitosan/CMC Drug-Loaded ParticlesPolyelectrolyte complex particles (2-10 μm) with 60-85% encapsulation efficiency provide sustained release (40-60% over 72 hours) and complete biodegradation in 4-6 weeks.
PHILIPPINE TEXTILE RESEARCH INSTITUTE (PTRI)Antimicrobial and UV-protective functional textiles for polyester/pineapple fiber blended fabrics in apparel and medical textile applications.ZnO/CMC Bio-Nanocomposite Textile TreatmentIn-situ synthesized ZnO nanoparticles in carboxymethyl chitosan matrix improve UV protection factor by 10-15% and provide bactericidal activity against Klebsiella pneumoniae and Staphylococcus aureus.
Reference
  • Hyperosmolar ophthalmic composition comprising carboxymethyl chitosan
    PatentPendingEP4667000A1
    View detail
  • N,o-carboxymethylchitosonium carboxylate salts
    PatentWO1996020221A1
    View detail
  • Itaconylated carboxymethyl chitosan cross-linked gel, preparation method therefor, and use thereof
    PatentWO2025139901A1
    View detail
If you want to get more related content, you can try Eureka.

Discover Patsnap Eureka Materials: AI Agents Built for Materials Research & Innovation

From alloy design and polymer analysis to structure search and synthesis pathways, Patsnap Eureka Materials empowers you to explore, model, and validate material technologies faster than ever—powered by real-time data, expert-level insights, and patent-backed intelligence.

Discover Patsnap Eureka today and turn complex materials research into clear, data-driven innovation!

Group 1912057372 (1).pngFrame 1912060467.png